Highest-materiality recent filing
Natural Health Trends Q2 revenue down 23% to $7.6M; net loss of $0.05 per share
Revenue $7.6M, down 23% YoY; operating loss $643K vs $333K loss in Q2 2025.
Approved 2026 Equity Incentive Plan authorizing up to 1,100,000 shares of common stock for equity awards.
NHTC Q1 2026 revenue $9.2M, down 14% YoY; net loss $154k vs prior year income
Revenue $9.2M, down 6% from Q4 2025 and 14% from Q1 2025.
NHTC repurchases all Broady family shares (~25.5% of outstanding) for $5.9M
Repurchased 2,935,227 shares (25.5% of outstanding) from George K. Broady trusts for $2.00/share, total $5.9M cash.
Natural Health Trends Q4 revenue $9.7M, net loss $0.05/share; full year revenue down 7%
Q4 revenue $9.7M, down 10% YoY but up 3% sequentially; net loss $588K ($0.05 diluted EPS).
Natural Health Trends Q3 loss widens; revenue down 11%; plans restructuring, dividend cut
Revenue $9.5M (-11% YoY); net loss $0.04/diluted share vs breakeven prior year.
NHTC Q2 2025 revenue $9.8M (-6% YoY); net income $15K vs $173K; dividend $0.20
Revenue $9.8M, down 6% from $10.5M in Q2 2024.
Natural Health Trends stockholders re-elect all five directors and ratify auditor at annual meeting
Yiu T. Chan, Randall A. Mason, Lucy N. Nduati, Chris T. Sharng, Ching C. Wong elected directors with For votes ranging from 5.2M to 6.0M.
Natural Health Trends Q1 revenue down 2% to $10.7M; net income $122K, dividend $0.20
Revenue $10.7M, down 2% YoY from $11.0M; operating loss $345K vs $365K in Q1 2024.
Natural Health Trends grants phantom shares to President and CFO with performance-based vesting
President Chris T. Sharng granted 124,850 phantom shares; CFO Timothy S. Davidson granted 41,788 phantom shares.
Natural Health Trends Corp. appoints CBIZ as independent auditor after Marcum acquisition
Marcum LLP resigned as auditor; CBIZ CPAs P.C. engaged as new independent registered public accounting firm for FY2025.
NHTC Q4 revenue $10.8M flat YoY, net income $176k; declares $0.20 dividend
Q4 revenue $10.8M (unchanged YoY); Hong Kong business up 7% YoY and 9% sequentially.
Natural Health Trends Q3 revenue up 1% to $10.7M; net income down 80% to $35K; dividend $0.20
Q3 2024 revenue $10.7M (+1% YoY); operating loss improved to $275K from $292K.
Natural Health Trends posts Q2 net income $173K vs loss; declares $0.20 dividend; elects director
Revenue $10.5M flat YoY; operating loss improved to $238K from $743K.
Natural Health Trends elects four directors, passes all proposals at 2024 annual meeting
All four director nominees elected: Yiu T. Chan, Randall A. Mason, Chris T. Sharng, Ching C. Wong.
Natural Health Trends Q1 revenue $11.0M (-8% YoY); sequential orders up 11%, first time in 6 years
Net income of $188K ($0.02 diluted EPS) vs $257K ($0.02) in Q1 2023.
NHTC Compensation Committee Waives Share Transfer Restriction for President's Divorce Settlement
Waiver allows President Chris T. Sharng to transfer 443,322 shares of Common Stock to his ex-spouse per Domestic Relations Order.
Natural Health Trends Q4 rev $10.9M (+3% QoQ, -13% YoY); FY rev $43.9M (-11%); div $0.20
Q4 net income $358K ($0.03 diluted EPS); FY net income $568K ($0.05 diluted EPS).
Natural Health Trends Q3 revenue down 9% to $10.6M; net income $172k; declares $0.20 dividend
Revenue $10.6M, down 9% YoY; operating loss $292k vs $145k loss in Q3 2022.
Natural Health Trends Q2 revenue down 21% to $10.5M; posts net loss of $0.02 per share
Revenue $10.5M vs $13.4M YoY (-21%); operating loss $743K vs income $215K.
Natural Health Trends 2023 annual meeting elects four directors, ratifies Marcum LLP
8,768,070 shares (76.0% quorum) voted at May 16 annual meeting.
Natural Health Trends Q1 revenue $11.9M (+3% YoY); first revenue increase since Q3 2021
Net income $257K ($0.02 diluted EPS) vs loss $105K ($0.01 loss) in Q1 2022; operating loss $394K.
NHTC awards restricted shares and phantom shares to executives and employees
97,900 restricted shares awarded on Feb 6 under 2016 Equity Incentive Plan, vesting quarterly over 3 years.
Q4 2022 revenue $12.5M, up 7% from Q3 but down 22% YoY; net income $188K ($0.02 diluted EPS).
Comp Committee waived performance criteria for Dec 15, 2022 phantom share vesting due to extraordinary China circumstances beyond company's control.
NHTC Q3 revenue down 18% YoY to $11.7M; declares $0.20 dividend
Revenue $11.7M vs $14.3M YoY (-18%); operating loss of $145K vs income $479K.
Compensation Committee amended Phantom Share Agreements for President Chris T. Sharng and CFO Timothy S. Davidson.
NHTC Q2 revenue down 17% YoY to $13.4M; net income $183K; declares $0.20 dividend
Revenue $13.4M, -17% YoY but +16% sequential; operating income $215K vs loss in Q1.
Amendment deems performance criteria satisfied for June 15, 2022 vesting date due to extraordinary business circumstances in China.
Natural Health Trends stockholders elect all five director nominees and ratify Marcum as auditor
Quorum of 73.7% (8,417,004 of 11,422,539 shares) represented at annual meeting on May 10, 2022.
Natural Health Trends Q1 revenue down 14% to $11.5M; posts operating loss
Revenue $11.5M, down 14% YoY from $13.5M.
Natural Health Trends Q4 revenue $16.1M, up 13% QoQ but down 3% YoY; FY net income $1.1M
Q4 revenue $16.1M (+13% vs Q3; -3% vs Q4 2020); operating income $487K vs $1.3M year ago.
Natural Health Trends Q3 revenue flat YoY at $14.3M; SEC and IRS investigations closed
Q3 2021 revenue $14.3M (+1% YoY); net income $471k ($0.04 diluted EPS).
SEC investigation of Natural Health Trends closed with no enforcement action
SEC notified company on Sept 30, 2021, that investigation concluded with no recommended enforcement action.
NHTC Q2 rev $16.2M (+20% QoQ), net income $229K; declares $0.20/share dividend
Revenue $16.2M, up 20% from Q1 2021 but down 2% YoY from $16.4M.
On July 29, 2024, the Board of Directors of the Company, upon the recommendation of the Company's Nominating and Corporate Governance Committee, expanded the size of the Board of Directors to five (5) members and elected Lucy Nduati as a director to fill the newly created directorship.
Brunde E. Broady resigned as a member of the Board of Directors on February 6, 2023, stating that her resignation was due to unforeseen circumstances in her personal life.
Max materiality 0.80 · Median 0.55 · Most common event earnings